✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Share

Our Company

May 11, 2018

Spotlight on Johnson & Johnson’s Bioethics Efforts

Spotlight on Johnson & Johnson’s Bioethics Efforts

Edwin Kuffner, M.D., Chief Medical Officer for Johnson & Johnson Consumer Inc.

May 04, 2018

The Answer for Indigenous Mothers? Native Midwives

The Answer for Indigenous Mothers? Native Midwives

Vàng Tả Mẩy, village ethnic minority midwife, with Chảo Tả Mẩy, a mother in Nậm Giang 2 village of Nậm Chạc commune, Bát Xát district, Lao Cai province

March 27, 2018

Read All About It! Our Epidemiology Publications Are Available to Anyone

Read All About It! Our Epidemiology Publications Are Available to Anyone

May 10, 2017

Scientific Excellence, Bioethics and Values-Driven Decision-Making

Scientific Excellence, Bioethics and Values-Driven Decision-Making

May 10, 2017

How our Scientific and Evidence-Based Approach to Real-World Evidence Helps Define Patient and Consumer Outcomes

How our Scientific and Evidence-Based Approach to Real-World Evidence Helps Define Patient and Consumer Outcomes

May 10, 2017

Preclinical Science: Driving Excellence in Safety at Johnson & Johnson

Preclinical Science: Driving Excellence in Safety at Johnson & Johnson

A photo of Gary Eichenbaum

July 15, 2021

Statement from Paul Stoffels, M.D., on the Occasion of the 2021 UN High-Level Meeting on HIV/AIDS

Statement from Paul Stoffels, M.D., on the Occasion of the 2021 UN High-Level Meeting on HIV/AIDS

July 12, 2021

One Way We Are Combatting Underrepresentation as Part of Our Race to Health Equity

One Way We Are Combatting Underrepresentation as Part of Our Race to Health Equity

March 10, 2021

A Message from Our Lead Director

A Message from Our Lead Director

March 10, 2021

To Our Shareholders

To Our Shareholders

December 18, 2020

Johnson & Johnson Announces Agreement in Principle with Gavi to Supply Janssen’s COVID-19 Vaccine Candidate
to Lower-Income Countries in 2021

Johnson & Johnson Announces Agreement in Principle with Gavi to Supply Janssen’s COVID-19 Vaccine Candidate
to Lower-Income Countries in 2021

December 17, 2020

Johnson & Johnson Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE is Fully Enrolled

Johnson & Johnson Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE is Fully Enrolled

See All Stories